Author

J. Li

Observed name: Junhao Li

Institution: Viva Biotech (China)

Observed institution: Viva Biotech (China)

ORCID: 0000-0002-1497-7993

Observed ORCID: 0000-0002-1497-7993

OpenAlex ID: A5121096735

Pep2MARS: Automated Cyclic Peptide Parameterization for Molecular Dynamics and Compound Design

2026 · Junhao Li, Yue Qian · Journal of Chemical Information and Modeling · 1

602O Efficacy and safety of HLX43 (an anti-PD-L1 ADC) in recurrent/metastatic cervical cancer (CC): A randomised, multicentre, phase II study

2025 · J. Yu, P. Xie, et al. · Annals of Oncology

65MO Neoadjuvant HLX11 versus European Union (EU)-sourced pertuzumab in human epidermal growth factor receptor 2 (HER2)-positive, hormone receptor (HR)-negative early or locally advanced, breast cancer (BC): A double-blind, randomised phase III equivalence study

2025 · Q. Liu, Y. Yang, et al. · Annals of Oncology

Works count: 3

Citation count: 1

H-index: 1

I10-index: